NAPROSYN 250mg Price

Overview

Welcome to Dwaey, specifically on NAPROSYN 250mg Tablets page.
This medicine contains an important and useful components, as it consists of Naproxen.
NAPROSYN 250mg is available in the market in concentration 250mg/Tablet and in the form of Tablets.

SYNTEX PHARMACEUTICALS LIMITED is the producer of NAPROSYN 250mg and it is imported from UK, The most popular alternatives of NAPROSYN 250mg are listed downward .

Mode Of Action

Naproxen, a propionic acid derivative, is a prototypical NSAID. It reversibly inhibits the cyclooxygenase-1 and -2 (COX-1 and -2) enzymes, thus resulting in reduced synthesis of prostaglandin precursors. It can inhibit platelet aggregation, has anti-inflammatory, analgesic and antipyretic actions.

Indication

• Rheumatoid arthritis
• Ankylosing spondylitis
• Post-operative pain
• Dysmenorrhea
• Acute gout
• Acute migraine attacks
• Renal colic
• Mild to moderate pain
• Tendonitis
• Osteoarthritis (degenerative arthritis)
• Acute musculoskeletal disorders
• Bursitis

Precaution

Patient w/ known CV disease or risk factors for CV disease, history of GI bleeding or peptic ulceration, fluid retention or heart failure. Hepatic and renal impairment. Elderly. Pregnancy and lactation. Patient Counselling May impair ability to drive and operate machinery. Monitoring Parameters BP should be monitored closely during initiation and throughout therapy. Perform periodically renal function, CBC and chemistry profile in patients receiving long-term therapy. Lactation: Drug excreted in breast milk; effect on infant unknown; not recommended

Side Effects

• 1-10% Abdominal pain (3-9%)
• Constipation (3-9%)
• Dizziness (3-9%)
• Drowsiness (3-9%)
• Headache (3-9%)
• Heartburn (3-9%)
• Nausea (3-9%)
• Edema (3-9%)
• GI bleeding (1-4%)
• GI perforation (1-4%)
• Lightneadedness (<3%)
• GI ulcers (1-4%)
• Fluid retention (3-9%)
• Diarrhea (1-3%)
• Stomatitis (<3%)
• Diverticulitis (1-3%)
• Dyspnea (3-9%)
• Hearing disturbances (<3%) <1% Meaningful (3 × upper limit of normal) elevation of serum alanine aminotransferase or aspartate aminotransferase

Contra indication

Hypersensitivity. Aspirin or NSAID allergy. Perioperative pain in the setting of CABG surgery. Pregnancy (3rd trimester).

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Pregnancy category: C; D in 3rd trimester or near delivery.